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Background: Some western countries recently have shown a slowdown in the incidence of allergic
diseases after worldwide increasing trends, but there are few data from Asian populations concerning
changing trend of allergic diseases. We evaluated the recent trends in the prevalence of asthma and other
allergic diseases in Korea.
Methods: From the database of Korean National Health Insurance, a nationwide diagnostic data from
2009 to 2014 were extracted and the national prevalence was analyzed.
Results: The prevalence per 1000 people of atopic dermatitis, allergic rhinitis, and asthma in 2014 was
19.0, 133.1, and 36.3, respectively. The prevalence of three diseases was highest in the age group under 10
as, 95.0, 384.1, and 132.1 per 1000 people, while the prevalence in the over-10-year-group was only 11.6,
109.5, and 27.3, respectively. The prevalence of atopic dermatitis and allergic rhinitis gradually decreased
with older age, but the prevalence of asthma showed a re-increasing pattern from the age group 30e39
and reached another peak for the age group 70e79. During the study period, the prevalence of asthma
and atopic dermatitis showed decreasing tendency. In contrast, the prevalence of allergic rhinitis steadily
increased until 2013, especially in the age group under 10.
Conclusions: The national prevalence of atopic dermatitis, and asthma did not show noticeable increase
any more in Korea. However, the prevalence of allergic rhinitis still on the rise until recently, especially in
the age group under 10. This is the ﬁrst report in Asia suggesting a slowdown of the incidence of allergic
diseases.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The burden of chronic allergic diseases was on the rise world-
wide for the past several decades, the so-called ‘allergic
epidemic’.1,2 However, whether this trend is still ongoing is ques-
tionable. Some recent reports inWestern developed countries have
already shown a stationary or even decreasing prevalence of
childhood allergic disease whereas there was still an increase in
prevalence in developing countries where the prevalence had beenty Hospital, 101 Daehak-ro,
ety of Allergology.
rgology. Production and hosting by Elsevery low in the past.3 In Asia, there is no data showing changing
trend in the prevalence of chronic allergic disease until recently.4,5
Epidemiologic data is important to establish a long-term health
care plan for chronic diseases. The heterogeneity and changes of
study methods makes it difﬁcult to integrate the epidemiologic
results of previous studies to assess changes over time. Therefore, a
longitudinal study based on a large standardized population is ideal
in order to obtain precise epidemiologic data. However, these
studies are costly as well as difﬁcult to perform.
Korea has a nationwide disease database that includes the
people of the entire country since a single mandatory government-
established nationwide insurance systemwas established in 1989.6
This database is optimized to evaluate serial trend of national
prevalence because it contains data of the entire national popula-
tion with the same method. We evaluated the recent trends of thevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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rhinitis, and asthma in Korea by analyzing data of nationwide in-
surance system.
Methods
Subjects
We performed a retrospective, population-based study to assess
the prevalence and its changing trend of atopic dermatitis, allergic
rhinitis, and asthma in Korea. All patients who ever visited any
medical facilities in Korea were included using nationwide claim
data from 2009 to 2014.
This study was exempted from full review by the institutional
review board of Seoul National University Hospital (number 1506-
009-676).
Data source
Korea has adopted the National Health Insurance (NHI) pro-
gram, which is a nationwide health insurance system providing
healthcare coverage to the residents in Korea. Although there are
several private medical insurances, the NHI program is the only
mandatory health insurance system regulated by the law covering
97.9% of the total population. At the same time, all physicians in the
country submit billing claims to the NHI program with diagnostic
codes.6 Health Insurance Review and Assessment Service (HIRA)
reviews and assesses medical fees paid by the NHI program and
provides a summary of nationwide annual statistical data on its
homepage (www.hira.or.kr) for the recent years. Age data was
available as 10-year age groups. Medical cost data from the HIRA
included whole expenses paid to clinics and hospitals except ex-
penses paid to pharmacies for medicines prescribed in outpatient
clinics. Demographic data including annual total and 10-year age
group population numbers registered in the NHI were extracted
from the Korean Statistical Information Service (KOSIS) homepage
(www.kosis.kr).
Data analysis
The data did not include any identiﬁcation information from the
individual patients. We used diagnostic codes from the Interna-
tional Classiﬁcation of Diseases-10 (ICD-10) to extract speciﬁc data
about atopic dermatitis, allergic rhinitis and asthma. The diagnostic
codes are L20 for atopic dermatitis, J301, J302, J303, and J304 for
allergic rhinitis, J45 and J46 for asthma.
The prevalence was determined by the number of patients with
each diagnostic code divided by the total registered number of
patients by the NHI. Means with standard error were used but we
did not present standard error because the study subjects
accounted for the total population of Korea. With the same reason,Table 1
Annual number of patients and costs at medical institutions for atopic dermatitis, allerg
2009 2010 2011
Number of patients
Atopic dermatitis 1,051,747 1,049,290 1,0
Allergic rhinitis 5,529,050 5,830,136 5,8
Asthma 2,377,683 2,245,778 2,2
Costs at medical institutiony
Atopic dermatitis 29,692,819 30,813,452 30,5
Allergic rhinitis 147,251,127 158,200,596 162,7
Asthma 175,184,735 168,862,394 170,0
y Expressed in U.S. dollar.other statistical values such as conﬁdence interval or p-value were
not presented either.
Results
Recent changes in the prevalence of three major allergic diseases
Table 1 shows the annual number of patients and costs spent at
medical facilities for atopic dermatitis, allergic rhinitis, and asthma
in Korea. The prevalence of the three diseases in 2014 was 19.0,
133.1, and 36.3 per 1000 people, respectively. The prevalence was
higher inwomen than in men, especially for allergic rhinitis (Atopic
dermatitis: 17.83 vs. 20.10; Allergic rhinitis: 123.15 vs. 143.18;
Asthma: 33.17 vs. 39.49 in 2014). For the past six years, the prev-
alence of allergic rhinitis continuously increased (yearly by 3.2% on
average) while that of atopic dermatitis and asthma slightly
decreased during the same period (yearly by 2.6% and 5.8% on
average) (Fig. 1).
Recent changes in the prevalence of allergic diseases in 10-year age
groups
For atopic dermatitis, the age group under 10 years old showed
the highest prevalence among the 10-year age groups. In 2014, the
prevalence of atopic dermatitis per 1000 people was 95.0 in the age
group under 10 years old but decreased to 11.6 in the age group
over 10 years old. Especially in people over 30 years old, the
prevalence of atopic dermatitis was below 10 per 1000 people. The
temporal trend in the prevalence of atopic dermatitis was sta-
tionary on average2.6% yearly change in general (yearly4.1% for
under 10 years old and 0.5% over 10 years old) (Fig. 2a).
The prevalence of allergic rhinitis was also the highest in the age
group under 10 years old. In 2014, the prevalence in the under 10
years old was 384.1 per 1000 people and was cut down to 109.0 per
1000 people in over 10 years old. In contrast to atopic dermatitis,
the prevalence of allergic rhinitis remained above 100 per 1000
people in people over 30 years old groups (Fig. 2b). For the recent 6
years, prevalence increase was yearly 3.2% on average especially
with the yearly 8.2% increase in the age group under 10 years while
the age group over 10 years showed relatively modest change
(yearly 2.1%).
In 2014, the prevalence of asthma per 1000 people was the
highest as 132.1 and 27.3 in the under and over 10 years old group,
respectively. Unlike atopic dermatitis and allergic rhinitis, the
prevalence of asthma showed two peaks. It reached the lowest in
the 20e29 years old group as 13.5 per 1000 people, the 50e59
years old group showed a distinct re-increase in the asthma prev-
alence, and the 70e79 years old group revealed another epidemi-
ologic peak as 66.3 per 1000 people. Regarding the trend in the past
six years, the prevalence of asthma decreased by yearly 5.8% on
average. In the under 10 years old group, there was more noticeableic rhinitis and asthma in Korea from 2009 to 2014.
2012 2013 2014
10,527 981,028 1,015,186 954,000
52,544 6,331,813 6,429,755 6,697,490
64,275 2,181,144 1,969,078 1,827,068
08,568 29,760,316 32,231,457 35,033,840
63,497 176,711,206 185,180,071 207,205,833
53,219 156,244,052 146,268,832 146,939,214
Fig. 1. Prevalence of allergic diseases in Korea.
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(yearly 7.1% and 3.7% on average, respectively) (Fig. 2c).
Fig. 3 shows population structures of the total population and
the patients of the three allergic diseases in 2014. The patient
population was the largest for all three diseases in the age group
under 10 years old despite its relatively small proportion in total
population. Among over 10 years old, the number of patients for
allergic rhinitis and asthma showed another peak in 30e39 and
50e59 years old group, respectively while atopic dermatitis
consistently decreased with older age.Burden of chronic allergic diseases: direct medical cost
Total cost paid to medical institutions by the NHI program in
2014 was 35.0, 207.2 and 146.9 million dollars for atopic dermatitis,
allergic rhinitis, and asthma, respectively (Table 1). Costs for atopic
dermatitis have changed less for the past six years while those of
allergic rhinitis have increased along with the rise of its prevalence
(yearly 3.4% and 7.1% change on average, respectively). The costs of
asthma have decreased yearly by 4.5% for the past six years (Fig. 4a).
The medical costs per person were 36.7, 30.9, and 80.4 dollars
for atopic dermatitis, allergic rhinitis, and asthma, respectively.
They have been increased for the past six years (yearly 5.4%, 3.0%Fig. 2. Prevalence of allergic diseasesand 1.8% on average for individual disease) (Fig. 4b) and it shows a
similar result when divided by the 10-year age groups.Discussion
The prevalence of chronic allergic diseases has increased for
several decades.1,2 However, the extent of the increase in allergic
diseases shows diversity according to countries. Some reports
investigating children in Western developed countries showed a
recent decreasing or stationary prevalence of allergic diseases in
contrast to the continued increasing prevalence of allergic diseases
in developing countries including the AsiaePaciﬁc region where
the prevalence had been relatively low in the past.3,4 In adults,
there are very few reports on the trends in the prevalence of allergic
diseases. This study was performed using serial data of the entire
nation covering all age groups and observed stationary or
decreasing patterns of their prevalence in adult population in
Korea.
The most important factor in analyzing the temporal changes
in the prevalence of chronic diseases is that a study must be done
with standardized procedures by using the same methods to
collect data every year. For the recent decade, there have been
sporadic epidemiologic studies on the prevalence of allergicdivided by 10-year age groups.
Fig. 3. Population structure of Korea and patients of allergic diseases.
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vey prevalence as well as deﬁnitions used to deﬁne allergic dis-
eases made it difﬁcult to integrate previous epidemiologic
studies to assess time-trends in prevalence. In this regard, NHI
database in Korea is the best option for epidemiologic survey
because its data are gathered by the same disease deﬁnitions
based on ICD-10 by physicians covering the whole nation. The
strength of this study include extensiveness of the nationwide
data collection and the standardized method for evaluating
temporal trends of the prevalence of allergic disease, unlike other
epidemiologic surveys concerning only a particular region or
institutions. This is the ﬁrst study with nationwide database to
suggest that the prevalence of chronic allergic diseases mightFig. 4. Total cost and cost per person phave reached a plateau or already have started to decrease in
Asian country.
According to previously reported literature, atopic dermatitis
generally affects up to approximately 25% of children and 2e3% of
adults.7 For children, eczema prevalence decreased in the 2000s in
developed countries such as New Zealand and the United Kingdom
where atopic dermatitis was highly prevalent in contrast to the
increasing tendency in developing countries especially in Asia or
Eastern Europe.8 In adults, the low prevalence of atopic dermatitis,
ranging from approximately 2e4%, seems to be stationary world-
wide for the recent several decades.9 In Korea, the overall preva-
lence of atopic dermatitis is assumed to be as high as 16.9e17.9% in
preschool children and 2.6e7.1% in adults based on theaid to medical institutions by NHI.
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year-old group, the prevalence of atopic dermatitis is highest in one
year old and it showed a signiﬁcant decreasewith age.12 In our data,
the prevalence of atopic dermatitis in the under and over 10 year-
old group was 9.5% and 1.2%, respectively and it did not show
remarkable changes in the past six years in both groups.
The prevalence of allergic rhinitis is also increasing in most
countries in the world, but it seems to have hit a plateau or even
decreased in previously highly prevalent areas such as Western
Europe or North America after the 2000s.13 The ISAAC studies
provide extensive data on allergic rhinitis in children. Excluding a
couple of countries showing extreme deviation, the worldwide
prevalence of allergic rhinitis is assumed to be 3e24% in 6e7 year-
old children and 4e28% in 13e14 year-old adolescents in the
2000s.3 However, there is no worldwide epidemiologic study in
adults and the results of prevalence surveys of some countries tend
to be very diverse, ranging from 3% to 34.5%, due to their various
deﬁnitions.13 In Korea, according to themost recent survey after the
2010s, the prevalence of allergic rhinitis was reported to be 34.5% in
preschool children and 16.2% in adults.10,14 The age showing peak
prevalence under 10 years old was 6e8 years.15 In our study, the
prevalence of allergic rhinitis in the age group under 10 showed
steep increasing pattern up to 2013 and reached 38.4% in 2014
while the prevalence in the age group over 10 was 11.0% with
relatively modest increase.
Asthma is one of the most common diseases in the world. The
prevalence of asthma has increased with urbanization, industrial-
ization and lifestyle change.16 However there are several reports
showing that international differences in asthma prevalence have
reduced in recent years, mostly in children and adolescents;
asthma prevalence is increasing in Asia, Africa, and South America
while decreasing in English-speaking countries and Western Eu-
ropean countries after the 2000s.1,17e20 Between phase I and II of
the ISSAC study with an interval of 5e10 years in 2000s, the mean
symptom prevalence of wheezing during the last one year
increased slightly from 13.2% to 13.7% worldwide but a marked
decrease was observed in English-speaking countries in the case of
children and adolescents.18 Although there are only a few studies
that show the changing trend of asthma prevalence in adults, some
investigators have reported no increase in asthma prevalence after
the 2000s based on symptoms in a young adult cohort in
Europe.21,22 In Korea, the prevalence of asthma was highest in 0e3
year-old group and decreased with age.23 It seems to be 5e8% in
children and reached a plateau in the 13e14 year group during 5-
year interval in the 2000s.3 The prevalence of adult asthma in Ko-
rea was estimated to be 2% in a survey performed in 200824 and
other report based on drug prescription data estimated it as 5.4% in
2010 and it showed continued increasing pattern until 2010.5 In our
data, the prevalence of asthmawas 13.2% and 2.7% in the under and
over 10 year old group in 2014, respectively. Both had a decreasing
prevalence during the recent six years and the changing trend in
asthma prevalence in Korea seems to have plateaued like in
Western developed countries.
Total cost paid to medical institutions by the NHI program was
35.0, 207.2 and 146.9 million dollars for atopic dermatitis, allergic
rhinitis and asthma, respectively. Each beneﬁt was ranked 158th,
26th and 34th.25 Medical costs per person for the past six years
have slightly increased and it shows a similar result when divided
by the 10-year age groups. In other literature about asthma, the
proportion of cost reimbursed by the NHI is for about 22.5% of the
total expenditure.26 Applying this information to our data, the total
cost for asthma management in Korea may be estimated to be 653
million dollars in 2014.
As mentioned above, atopic dermatitis, allergic rhinitis and
asthma have rapidly increased for the past several decadesworldwide with urbanization and industrialization.2,13,27 There are
some hypotheses explaining the cause of this phenomenon,
including the hygiene hypothesis.28 In addition, there are many
possible risk factors to explain ‘allergic epidemic’ such as allergen
levels in the air, diet change, smoking, vaccination level, exposure
to pets, socioeconomic status, etc.28e32 However, there are several
studies suggesting that the prevalence of chronic allergic diseases
has plateaued or decreased recently in some countries, especially in
children and young adults.1,3,8,18,21,22 Risk factors or a hygiene hy-
pothesis cannot fully explain this phenomenon. In the ISSAC trial,
discordance in prevalence in the 6e7 and 13e14 year age-groups
was explained with the collapse of the communist system of
Europe in the 1990s.3 Therefore, the trends in epidemiology would
be more explainable by taking into account social and environ-
mental changes.
Our data showing that the recent prevalence of allergic diseases
in Korea are not increasing suggests several important points to
understand current epidemiology of allergic diseases. First, it might
be reﬂection of changing disease patterns keeping pace with rapid
transition to an industrialized society. As Korea went through
extremely rapid urbanization and industrialization from the 1960s
to the 1990s, residential environment and hygiene dramatically
changed: family size diminished, and lifestyle became similar with
those of western countries. From the 2000s, the urbanization and
industrialization of Korea was almost completed, and Korea
reached post-industrialization era.33,34 While the prevalence of
chronic allergic diseases up until recently in Korea reﬂects the rapid
urbanization and industrialization before the 2000s, it seems to
come up to the plateau by the completion of rapid industrialization
after the 2000s. Recent changes of trend according to change of
society are important to expect the future pattern of allergic dis-
eases in other countries which have been on a similar development
process. Second, our data show that there are still age groups of
which prevalence is higher than other group even though overall
prevalence does not increase. In under 10 year-old group, preva-
lence of all three diseases is higher than over 10 year-old group and,
moreover, that of allergic rhinitis is still increasing. In fact there are
many potential factors inﬂuencing allergic diseases in children but
it is still unknown whether and how they contribute to the devel-
opment of allergic disease in childhood.35 It emphasizes that the
unmet needs for proper management and prevention of allergic
disease in children.
Our data has several limitations. First, since we estimated
prevalence with medical insurance data, only those who received
medical treatment were enrolled. Several surveys report that only
25e74% of patients with asthma symptoms visit clinics or hospitals
for treatment.36,37 Therefore, the prevalence in our data might be
somewhat underestimated and inﬂuenced by socioeconomic status
and medical environment. Second, we used the open data of HIRA
and additional information was not accessible. Therefore we could
not analyze the peak age of prevalence.
However, it contains data about entire country of large sample
size more than 50 million, which was not attainable with survey.
The method for data collection was uniform and standardized
during study period. In addition there was no considerable change
in medical issues in diseases such as new drug or treatment, new
approval of over-the-counter drug. The report of which population
of this size showing changing trend of prevalence in chronic allergic
disease is the ﬁrst one in Asia and it might be important because it
implies that such a trend is not limited to western countries
anymore and possibility of change in future epidemiology of
chronic allergic diseases in other Asian countries.
We analyzed recent prevalence changes of atopic dermatitis,
allergic rhinitis and asthma using nationwide insurance data
collected with a uniform method and condition covering the entire
B.-K. Kim et al. / Allergology International 65 (2016) 186e191 191nation. The recent prevalence of these diseases did not show rapid
increase any longer in adult population in Korea similar to Western
developed countries while still increasing trend of allergic rhinitis
in children under 10 year old.Acknowledgments
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